. However, many research and clinical applications still depend upon improved efficiency, cell viability, and generalizability of non-viral genome targeting across cell types [1] [2] [3] [4] . We previously found that varying the relative concentrations of both Cas9 RNP and HDR template had significant effects on targeting efficiency 3 and toxicity
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Virus-modified T cells are approved for cancer immunotherapy, but more versatile and precise genome modifications are needed for a wider range of adoptive cellular therapies [1] [2] [3] [4] . We recently developed a non-viral CRISPR-Cas9 system for genomic site-specific integration of large DNA sequences in primary human T cells 5 We recently reported an approach to reprogram human T cells with CRISPR-based genome targeting without the need for viral vectors 5 . However, many research and clinical applications still depend upon improved efficiency, cell viability, and generalizability of non-viral genome targeting across cell types [1] [2] [3] [4] . We previously found that varying the relative concentrations of both Cas9 RNP and HDR template had significant effects on targeting efficiency and toxicity 5 . Here, we set out to optimize the interactions between the HDR template and stabilized RNPs to further improvement genome editing efficiency independent of cell type.
We devised a novel approach to promote nuclear entry of the template. Unlike previous efforts utilizing complex covalent linkages 7 , we attempted to recruit Cas9 RNPs with nuclear location sequences (NLS) to the HDR template by enhancing Watson-Crick interactions.
CRISPR-Cas9 interacts specifically with both genomic and non-genomic dsDNA 8 , and nucleaseinactive dCas9 has been used in many applications to localize protein and RNA effectors to specific DNA sequences without cleaving the target sequence 9 . We therefore tested if we could enhance HDR by targeting a dCas9-NLS 'shuttle' to the ends of an HDR template by coding 20
bp Cas9 Target Sequences (CTS) at the ends of the homology arms. Indeed, CTS-modified HDR templates mixed with dCas9-NLS RNP did show mild improvements in HDR efficiency in primary human T cells (Supplementary Fig. 1 ) but required two distinct RNPs. These data encouraged us to search for a simplified method utilizing the same RNP to both cut a specified genomic site and recruit Cas9-NLS to HDR templates.
We hypothesized that a single catalytically-active Cas9-NLS RNP would suffice for both on-target genomic cutting and 'shuttling' if the HDR template was designed with truncated (16bp) Cas9 Target Sequences (tCTS) that enable Cas9 binding but not cutting 10 ( Fig. 1a and Supplementary Fig. 2 ). With the proper sequence orientation, the additional tCTS markedly improved knockin efficiency of a 1.5kb DNA sequence inserting a reprogrammed TCRα and TCRβ specificity at the endogenous TRAC (T-cell receptor α constant) locus ( Fig. 1b and Supplementary Fig. 2 ). This tCTS shuttle system also improved genome targeting efficiencies across a variety of loci in different primary human T cell subsets (Fig. 1c,d and Supplementary   Fig. 3 ). HDR templates with the tCTS achieved preferential targeting even in direct competition with unmodified dsDNA HDR templates simultaneously delivered to the same cells ( Fig. 1e and Supplementary Fig. 4) . Additionally, the tCTS shuttle improved efficiencies of bi-allelic and multiplexed targeting across different loci ( Fig. 1f and Supplementary Fig. 4 ). The full HDR efficiency gains critically depended on the presence of an NLS in the Cas9 RNP, use of an ontarget gRNA, and pre-incubation of the Cas9-NLS RNP with the tCTS-modified HDR template ( Fig. 1g and Supplementary Fig. 5 ).
Taken together these data demonstrate that coupling the HDR template with tCTS to a Cas9-NLS RNP enhances genome targeting efficiency without requiring modification of the protein or gRNA.
Exogenous DNA (including HDR templates) can be cytotoxic at high concentrations 4, 5, 11 .
We therefore assayed the effects of the RNP-HDR template interactions on cell viability. Gene targeting using tCTS-modified HDR templates improved efficiency, but we observed decreased cell viability at DNA doses lower than unmodified dsDNA HDR templates (Fig. 1h) . Decreased viability was only observed with an on-target gRNA and pre-incubation of the RNP with HDR template, but did not entirely depend on the presence of a NLS on Cas9 ( Supplementary Fig. 5 ) consistent with possible enhanced cytoplasmic delivery of DNA during electroporation due to the RNP-HDR template interaction.
In previous experiments, we observed that Cas9 RNP co-delivery could mitigate exogenous DNA toxicity (to unmodified plasmids or dsDNA template) in human T cells 5 . We therefore wondered whether optimizing RNP delivery could improve cell viability. We noted that the Cas9 protein itself appears to be only quasi-stable when complexed with guide RNA; a molar excess of protein (RNA to Cas9 protein molar ratio of <1.0) results in a milky opaque solution with rapid sedimentation (Fig. 2a) of poorly functional material (Supplementary Fig. 6a ). Previous reports have suggested that RNP electroporation can be improved with addition of extra sgRNA or a non-homologous single strand DNA enhancer (ssODNenh) 12 . Excess guide RNA or addition of ssODNenh dispersed the Cas9 RNPs (Supplementary Fig. 6b ) and boosted editing efficiency of electroporated RNPs (Supplementary Fig. 6c ). However, combination of both guide RNA and ssODNenh in excess did not further improve editing (Supplementary Fig. 6c ), suggesting a possible shared mechanism of action.
We hypothesized that the polymeric and anionic nature of nucleic acids shields excess positively-charged residues of the Cas9 protein from nearby exposed portions of Cas9-bound gRNA, thus preventing aggregation and improving RNP particle stability. We therefore screened various commercially-available water-soluble biological and synthetic polymeric materials for the ability to also enhance electroporation-mediated Cas9 knock-out editing. Multiple different anionic polymers such as poly(glutamic acid) (PGA), poly(aspartic acid), heparin, and poly(acrylic acid) all enhanced editing efficiency in a dose-dependent manner without addition of ssODNenh or excess gRNA (Fig. 2b, Supplementary Fig. 7 ). The charge-neutral material poly(ethyleneglycol) (PEG) had only minimal impact on RNP activity; positively charged polymers poly(ethylenimine), protamine sulfate, poly-L-lysine, poly-L-ornithine, and poly-L-arginine all reduced editing efficiency (and viability) (Fig. 2b) , thus establishing anionic charge as a key factor for RNP enhancement. Further, enhancement of RNP-based editing depended upon polymer chain length ( Supplementary Fig. 7 ) similar to the reported length-dependence of ssODNenh 12 and consistent with colloid-stabilizing biomaterials 13 . Comparison of particle sizes by dynamic light scattering revealed that Cas9 protein by itself is 10-15nm in diameter as expected for dispersed individual molecules, but aggregates of ~200+ nm size were formed when gRNA was added ( Fig. 2d and Supplemental Fig. 8) . However, the addition of either PGA or ssODNenh prevented aggregation into micron-sized particles and improved the size distribution of RNP nanoparticles to less than 100nm on average, (Fig. 2d) with peaks in the 20nm and 100-120nm ranges ( Supplementary   Fig. 8 ).
We thus tested if anionic polymers could also enhance non-viral knockin genome targeting. When mixed with Cas9 RNPs and a reduced concentration of an unmodified dsDNA template targeting integration of a Rab11a-GFP fusion, PGA was effective at enhancing knockin editing in primary T cells (Fig. 2e) . PGA-stabilized RNP nanoparticles promoted efficiency gains in primary human T cells ( Fig. 2f ) and appeared to reduce the toxicity of higher doses of HDR template ( Fig. 2g) . These efficiency gains were independent of the order of PGA addition, guide RNA source, or Cas9 nuclease manufacturer (Supplemental Figs. 9-12). RNP stabilization with PGA (but not ssODNenh) also permitted lyophilization with retained knockout and knockin editing activity ( Fig. 2h, Supplementary Fig. 13 ). PGA-stabilized RNP nanoparticles therefore enhance edited cell viability and could be stored dry enabling significant streamlining of gene modified cell manufacturing for research or clinical translation.
We next examined if combining the tCTS 'shuttle' and anionic polymers could further improve efficiency and viability of non-viral genome targeting. The tCTS-modified HDR templates with PGA-stabilized RNPs markedly enhanced efficiency and viability in primary human T cells across multiple genomic loci ( Fig. 3a) . Importantly, the dose-dependent toxicity observed with the tCTS-modified HDR template ( Fig. 1h ) was mitigated by PGA-stabilized RNPs and improved the recovery of viable T cells edited at a variety of endogenous loci (Fig. 3b) . Increased efficiency and cell recovery were consistent across human blood donors and were most profound at lower concentrations of HDR template DNA (Supplementary Fig. 14) . The combined tCTS-modified HDR template and PGA-stabilized nanoparticle system also retained activity through freeze-thaw cycles and the lyophilization process ( Supplementary Fig. 15 ).
Encouraged by these results in T cells, we applied the combined system to enable nonviral genome targeting in a wider set of therapeutically relevant primary human hematopoietic cells. Using a Clathrin-GFP fusion template, which should be expressed in all tested cell types, we consistently observed improved editing efficiencies with the combined system ( Fig. 3c-e) . Bulk CD3+ T cells, purified CD4+ T cells or CD8+ T cells, and purified CD127low CD25+ CD4+ regulatory T cells (Tregs) all achieved a similarly high knockin efficiency of up to > 50% of cells, with 3-8x increase in the percentage of knockin edited cells at reduced HDR template concentrations ( Fig. 3c,d ). While standard RNP and unmodified HDR template achieved only minimal knockin in isolated primary human NK cells or B cells, the combined system resulted in over 15% transgene-positive cells and a 2-5-fold increase in edited cell yield ( Fig. 3c-e) . In γδ-T cells the combined system exhibited improved editing efficiency from ~5% to ~28%, and 5-6 fold improved edited cell recovery compared to a standard RNP and unmodified HDR template.
Finally, we were able to express large transgene insertions in over 15% of human HSPCs without a viral vector, in both primary mobilized peripheral blood-and iPS-derived 6 CD34+ HSPCs, with a marked viability boost and 2-3x increased yield of edited cells. The combined non-viral system was thus demonstrated to be effective in diverse human hematopoietic cell types.
Together, PGA as a RNP nanoparticle-stabilizing enhancer and the tCTS-modified HDR template enabled high percentage editing with improved edited cell yields in a variety of primary hematopoietic cell types opening the door to next-generation adoptive cell therapies beyond T cells. The combined nanoparticle-tCTS template system is a novel platform to explore gene function in clinically-relevant cell types that had been previously challenging to genome modify. hematopoietic stem cells were purchased from StemExpress Inc and cultured at 0.5e6 cells/mL in SFEM II media supplemented with CC110 cytokine cocktail (STEMCELL) for two days prior to electroporation. Induced pluripotent stem-cells were generated and differentiated into CD34+ HSPCs as previously described 6 then cultured in SFEM media (STEMCELL) supplemented with IL-2 at 10ng/mL, IL-6 at 50ng/mL, SCF at 50ng/mL, FLT-3L at 50ng/mL, and TPO at 50ng/mL (Peprotech).
RNP Formulation with Polymers
Cas9 RNPs were formulated immediately prior to electroporation, except when frozen or lyophilized as indicated. Synthetic crRNA (with guide sequence listed in Supplementary Table 1) and tracrRNA were chemically synthesized (Edit-R, Dharmacon Horizon or Integrated DNA Technologies (IDT)),resuspended in 10 mM Tris-HCL (7.4 pH) with 150 mM KCl or IDT duplex buffer at a concentration of 160 µM, and stored in aliquots at -80C. To make gRNA, aliquots of crRNA and tracrRNA were thawed, mixed 1:1 by volume, and annealed by incubation at 37C for 30 min to form an 80 µM gRNA solution. For comparison, chemically modified gRNA was purchased from Synthego and resuspended according to manufacturer's protocol. Cas9-NLS, dCas9-NLS, or Cas9 without NLS was purchased from the UC Berkeley QB3 MAcrolab; HiFiCas9 was purchased from IDT. To make RNPs, gRNA was then further diluted in buffer first, or directly mixed 1:1 by volume with 40 µM Cas9-NLS protein to achieve the desired molar ratio of gRNA:Cas9 (2:1 ratio unless otherwise stated). Unless otherwise stated, final dose of RNP per nucleofection was 50pmol on a Cas9 protein basis.
For initial screening, polymers were purchased dry (see Supplementary Table 2 ) and resuspended to 100mg/mL in water except as noted, passed through a 0.2 um syringe filter, and Long double-strand HDR templates encoding various gene insertions (see Supplementary Table   1 ) and 300-350bp homology arms were synthesized as GeneBlocks (IDT) and cloned into a pUC19 plasmid, which then served as a template for generating a PCR amplicon. Specific PCR primers targeting the left and right homology arms and with additional described Cas9 Target Sequences (CTS) (see Supplementary Figure 2 ) were synthesized (IDT) without chemical modifications. Amplicons were generated as previously described 5 with KapaHiFi polymerase (Kapa Biosystems), purified by SPRI bead cleanup, and resuspended in water to 0.5 to 2 ug/uL measured by light absorbance on a NanoDrop spectrophotometer (ThermoFisher). HDR templates were mixed and incubated with RNPs for at least 5 minutes prior to mixing with and electroporating into cells. Cytometry data was processed and analyzed using FlowJo software (BD Biosciences). (a) Enzymatically active Cas9-NLS RNPs can bind truncated Cas9 target sequences (tCTS) added to the ends of an HDR template.
(b) "In" facing orientation of the tCTSs (PAM facing in towards the center of the inserted sequence vs "out" away from the insert) on the edges of both the 5' and 3' homology arms improved knockin efficiency of a new TCR-TCR specificity at the endogenous TRAC locus.
(c) Representative flow cytometry plots showed improved targeting efficiency across target genomic loci with the tCTS modifications compared to an unmodified dsDNA HDR template.
(d) The tCTS modifications improved targeting efficiencies of large knockins across eight genomic loci tested in both CD4+ and CD8+ T cells. Note CD4-GFP expression was not observed at relevant levels in CD8+ T cells, as expected.
(e) Multiplexed electroporation of GFP and RFP knockin templates to the RAB11A locus where neither, one, or both templates had a tCTS modification revealed direct competitive knockin advantage of 'shuttle' system compared to unmodified dsDNA template (technical replicates from n=2 donors).
(f) The tCTS modification improved multiplexed dual knockin at different genomic loci as well as bi-allelic knockin at a single target locus (technical replicates from n=2 donors).
(g) Full improvement of knockin efficiencies with the tCTS modifications were dependent on Cas9-NLS protein (multiple technical replicates from n=2 donors). . PGA (blue circles outlined in red) with chemical structure shown inset above data point that corresponds to 100mg/mL concentration. Each polymer sample was tested at serial dilutions to avoid potential dose-dependent cytotoxicity falsely masking impact on editing efficiency, and each concentration is depicted as an individual point that is an average for two different blood donors.
(c) Cas9 RNPs at 0.5 molar ratio of gRNA:protein (prepared same as in (a)) could be further dispersed with addition of PGA or ssODNenh, whereas dilution with water alone had no visible benefit.
(d) PGA and ssODNenh stabilized and reduced the size of RNP nanoparticles. Cas9 RNPs prepared at 2:1 molar ratio of gRNA:protein alone (RNP) or mixed with PGA or ssODNenh were assessed for hydrodynamic particle size by dynamic light scattering. Z-average particle size is shown for n=2 independent preparations each averaged over ten repeated measurements (individual sample size distributions and peaks shown in Supplementary Fig. 8 ).
(e) Multiple anionic polymers boosted knockin editing efficiency. Polymers mixed with Cas9 RNPs prepared at a 2:1 gRNA:protein ratio were further mixed with 1ug unmodified dsDNA HDR templates (targeting insertion of an N-terminal fusion of GFP to Rab11a), electroporated into CD4+ T cells, and editing efficiency were assessed by flow cytometry at day 3. The relative rates of HDR is displayed compared to unmodified dsDNA HDR template without enhancer. Two technical replicates shown for two different blood donors each.
(f) PGA-stabilized Cas9 RNPs prepared at a 2:1 ratio gRNA:protein markedly improved knockin editing in primary human Bulk (CD3+) T cells targeting a C-terminal fusion of GFP to clathrin and (g) improve viability of electroporated cells (compared to untreated cells). Data shown as average from two different blood donors.
(h) Cas9 RNPs prepared at a 2:1 ratio gRNA:protein without or with PGA or ssODNenh were mixed with 1ug of unmodified dsDNA HDR template targeting an N-terminal fusion of GFP to RAB11A, lyophilized overnight, stored dry at -80C, then later reconstituted in water prior to electroporating into primary human CD3+ (Pan) T cells. PGA-stabilized Cas9 nanoparticles were protected through lyophilization and reconstitution and retained activity for robust knockin editing. 
